SCHEMBL6174416

SCHEMBL6174416

CCN(CC)CCOC(=O)Nc1cc(C(C)C2NC(=O)N(c3ccc(S(=O)(=O)C(F)(F)F)cc3)C2=O)ccn1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.33
CBLB Q13191 2/20 0.32
HRH4 Q9H3N8 1/20 0.30
SYK P43405 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172454 0.91 GAA (0.36) IGF1RCBLBSYK
SCHEMBL6175377 0.90 IGF1R (0.35) IGF1RCBLBSYK
SCHEMBL6175310 0.88 MCHR1 (0.35) CBLB
SCHEMBL6174445 0.88 IGF1R (0.43) IGF1R
SCHEMBL6173893 0.83 LMNA (0.39) IGF1RCBLB
SCHEMBL6172184 0.80 NPC1 (0.39) IGF1RCBLB
SCHEMBL6174110 0.80 NPC1 (0.39) IGF1RCBLB
SCHEMBL6176337 0.79 NPC1 (0.39) CBLB
SCHEMBL6174018 0.79 SLC5A1 (0.36) IGF1RCBLBSYK
SCHEMBL6173894 0.79 IGF1R (0.37) IGF1RHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed